The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-imidazol-1-yl-but-2-en-1-one ID: ALA4634499
PubChem CID: 78321979
Max Phase: Preclinical
Molecular Formula: C30H24ClFN6O3
Molecular Weight: 571.01
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(/C=C/Cn1ccnc1)N1CCOc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc21
Standard InChI: InChI=1S/C30H24ClFN6O3/c31-24-14-22(6-7-27(24)41-17-20-3-1-4-21(32)13-20)36-30-23-15-26-28(16-25(23)34-18-35-30)40-12-11-38(26)29(39)5-2-9-37-10-8-33-19-37/h1-8,10,13-16,18-19H,9,11-12,17H2,(H,34,35,36)/b5-2+
Standard InChI Key: QNTIYLZUSHSUDA-GORDUTHDSA-N
Molfile:
RDKit 2D
41 46 0 0 0 0 0 0 0 0999 V2000
5.1384 -5.6791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1384 -6.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8478 -6.9049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8478 -5.2622 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5572 -5.6791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5556 -6.4986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2598 -6.9059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2590 -5.2685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9679 -5.6763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9671 -6.4986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6783 -6.9065 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3907 -6.4975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3875 -5.6721 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6758 -5.2637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6730 -4.4424 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3834 -4.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0959 -4.4428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8059 -4.0325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8035 -3.2103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0853 -2.8002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3783 -3.2170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5189 -4.4390 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
11.5134 -2.7942 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2272 -3.2036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9329 -2.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6437 -3.2010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3531 -2.7856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3497 -1.9634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6309 -1.5584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9244 -1.9720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0667 -3.1953 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.8478 -4.4409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5596 -4.0323 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1360 -4.0323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4241 -4.4409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7123 -4.0323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0005 -4.4409 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2455 -4.1075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6947 -4.7160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1034 -5.4279 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9066 -5.2592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 1 0
2 3 1 0
3 6 1 0
5 4 1 0
5 6 2 0
6 7 1 0
7 10 2 0
9 8 2 0
8 5 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
18 22 1 0
19 23 1 0
23 24 1 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 25 1 0
27 31 1 0
4 32 1 0
32 33 2 0
32 34 1 0
34 35 2 0
35 36 1 0
36 37 1 0
37 38 1 0
38 39 2 0
39 40 1 0
40 41 2 0
41 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 571.01Molecular Weight (Monoisotopic): 570.1582AlogP: 5.92#Rotatable Bonds: 8Polar Surface Area: 94.40Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 6.76CX LogP: 5.00CX LogD: 4.94Aromatic Rings: 5Heavy Atoms: 41QED Weighted: 0.23Np Likeness Score: -1.53
References 1. Sun M, Jia J, Sun H, Wang F.. (2020) Design and synthesis of a novel class EGFR/HER2 dual inhibitors containing tricyclic oxazine fused quinazolines scaffold., 30 (9): [PMID:32139324 ] [10.1016/j.bmcl.2020.127045 ]